Abstract. Mouse IgG and IgA, with reactivity to dinitrophenol conjugated to carrier protein, have been isolated from myeloma proteins by means of a variety of affinity techniques. The IgA was predominantly in the dimeric form. The in vitro and in vivo biological activities of IgA-containing immune complexes were assessed in the rat.
Introduction
During the last few years there has been. an expanding body of information that indicates the phlogistic potential of immune complexes in initiating inflammatory reactions in the lung. Increasing evidence suggests a role for immune complexes in human pulmonary diseases such as the idiopathic interstitial pneumonias (1) (2) and in collagen vascular diseases such as systemic lupus erythematosus (3) . Experimentally, numerous studies using polyclonal IgG immune complexes have clearly shown the ability of these complexes to induce acute lung injury that is complement-and neutrophil-dependent (4-6) and linked to the generation of oxygen-free radicals from neutrophils (7) .
Whereas good experimental evidence that IgG immune complexes are tissue damaging exists, the same cannot be said for IgA. Although IgA is present in high concentrations in mucosal secretions, including bronchial fluids, no direct evidence is present to suggest that IgA may have pathogenic potential. On the other hand, there is some evidence to suggest that IgA may be pathogenic in the kidney and in blood vessels. Based on observations in human diseases, IgA and the third component of complement (C3)' deposits have been identified in the glomerular mesangium of patients with Berger's IgA nephropathy (8) and in vessels, as well as glomeruli, of individuals with Hen-och-Schonlein purpura (9) . Experimentally, the vascular infusion into mice of preformed immune complexes containing IgA reportedly causes a mild acute nephropathy, as reflected by the development of a transient hematuria (10) . Finally, oral immunization of mice with bovine gamma globulin results in the mesangial deposition of immune complexes that contain IgA and the antigen, bovine gamma globulin, indicating that renal deposits of IgA may be the result of local, gut-associated immune responses to oral antigen (1 1) .
The studies to be presented indicate that IgA-containing immune complexes can cause acute injury in rat lung. Fur [BSA] ) in a volume of0.25 ml in phosphate-buffered saline (PBS) (pH 7.4) was injected into the airways during inspiration via a fine teflon catheter. The catheter was then removed and the incision was closed with silk suture. The DNP-BSA antigen at a dose of 3.3 mg was then injected intravenously.
Pulmonary injury. The resulting pulmonary injury was quantitated by previously described methods (4, 7) . Briefly, 1 ug BSA (labeled with 1251) was injected intravenously with the antigen. After 4 h the animals were killed by an intraperitoneal injection of ketamine followed by transection of the vena cava. Exactly 1.0 ml of blood was collected and the amount of radioactivity was assessed. Then the trachea and mediastinal contents were removed en bloc and 10 ml ofsaline was perfused through the right ventricle of the still-pumping heart to remove blood remaining in the pulmonary vascular system. The lung perfusate was allowed to exit from the aortic arch. Remaining radioactivity in the lung which represented extravascular albumin was then measured in a crystal scintillation counter. The ratio of this value to the amount of radioactivity in 1.0 ml blood was calculated as a measurement of lung injury.
Neutrophil depletion procedures. Rats were depleted of circulating blood neutrophils by the intraperitoneal injection of 1.0 ml serum obtained from rabbits immunized with rat neutrophils (4). 12 h later (when the animals were used for the experiments) there were <500 neutrophils/ ml blood as defined by total and differential blood cell counts. This compares with a typical neutrophil count assessed in 10 normal rats of 3,809±228 cells/mm3 (mean±SEM). The numbers ofmononuclear cells (lymphocytes and monocytes) and platelets were not affected by this treatment.
Complement depletion procedures. In studies where the role of the complement system in lung injury was assessed, selective complement depletion was accomplished by the administration of purified cobra venom factor as originally described by Cochrane et al. (12) . Cobra venom factor administration caused a nearly total depletion of C3 (with <5% remaining as determined immunochemically), thus blocking activation of both the classical and alternative pathways of the complement system.
Morphologic studies. At the time of death, fresh lung tissue was processed for immunofluorescence examination and for transmission electron microscopy. For immunofluorescence, the tissue was snap-frozen in liquid nitrogen, and lung sections were stained for the presence of IgA. For electron microscopy studies, the lungs were inflated with glutaraldehyde, and after fixation, ultrathin sections were obtained and processed for ultrastructural analysis.
Morphometric studies oflung. Plastic embedded sections (1I m thick) of lung tissue stained with toluidine blue were obtained from animals treated with the various reagents listed above. 30 different interstitial capillaries and alveoli from each of three rats per group were examined by morphometric techniques. These structures had been randomly selected for analysis with a photoscope II with a 40X objective (Carl Zeiss, Inc., New York). This instrument was connected electronically to a high resolution television camera which in turn was linked to a Video-Plan (Carl Zeiss, Inc.) that contained a television screen. The instrument was programmed to permit measurement of: (a) the length of endothelial surfaces in interstitial capillaries; (b) the amount of the surface involved with bleb formation; (c) the number of neutrophils within capillaries; (d) the length of alveolar surfaces; and (e) the numbers of erythrocytes within alveolar compartments. Areas to be measured were outlined on the television screen with an electronic wand and the measurements fed into a computer for analysis. Further details of these techniques are provided in a recent publication (13).
In vitro studies with IgA and rat neutrophils. Peritoneal neutrophils were harvested from rats that received 30 ml of 1% glycogen (Sigma Chemical Co., St. Louis, MO) in PBS 4 h earlier. These cells, of which >98% were neutrophils, were then incubated with preformed immune complexes containing DNP-BSA and IgA antibody (obtained by affinity chromatography). The amount of superoxide (°2) produced by 2 x 106 cells was determined by techniques recently described in detail (14) .
Measurement of complement activation by immunofixation. Complement activation was assessed by immunofixation techniques. The general procedures as outlined by Ritchie and Smith (15) Gel electrophoresis. Slab gels (1.5 X 160 cm) containing 10% polyacrylamide (37 to I ratio of acrylamide to bis-acrylamide) were produced using the SDS discontinuous buffer system described by Laemmli (19) .
Samples (100 IAI) prepared in SDS buffer were subjected to electrophoresis at a constant current of 30 mA until the bromphenol-blue dye front reached the bottom of the gel. After electrophoresis, the gels were immediately fixed in 50% methanol, 10% acetic acid, and 0.5% Coomassie Blue R250 for 30 As shown in the top of Fig. 3 , turbidity developed as the ratio of antigen to antibody increased. This was indicative of precipitating immune complexes which formed over a rather wide range ofantigen until very high concentrations ofantigen (400-800 gg) were reached, at which point there was evidence of increasing solubilization of the complexes.
The ability of these complexes to interact with neutrophils and bring about their activation as measured by production of O°is shown in the bottom of Fig. 3 . It can be seen that increasing amounts of antibody in the presence of antigen were able to activate neutrophils, leading to O°generation. The neutrophil activation was associated with the amount of antibody present in the complexes, as well as with the ratio ofantigen to antibody, with increasing production of O2 as the amount of antigen increased. These data suggest that both the insoluble complexes and those rendered more soluble in antigen excess were able to activate neutrophils to bring about 0°generation.
Studies of the biological effects on rat neutrophils of IgA immune complexes were extended with the use of preformed IgA immune complexes with DNP-BSA as antigen (Fig. 4) . These studies included complexes with three different ratios of antigen to antibody (1:1 to 4:1). The activation of neutrophils was directly proportional to the amount of complex added to the cells and was also affected by the ratio ofantigen to antibody. Similar studies were carried out with rat alveolar macrophages, but the DNP alone caused nonspecific cell activation such that definitive studies with the immune complexes were impossible.
Complement fixation induced by IgA immune complexes.
The next series of experiments was designed to determine ifthe 5) . In data not shown, the intravenous injection and the airway instillation of saline resulted in a lung permeability value of 0.25. deprived but neutrophil-intact animals that received the same dose of IgA antibody into the lungs showed a value of 0.35±0.02, whereas neutrophil depleted animals treated similarly had a mean lung permeability of 0.25±0.01 (Table III, experiment  B) . In complement-depleted animals, which received IgA antibody into the airways and antigen intravenously, a lung permeability value of 0.49±0.03 was measured, indicating a 65% reduction in lung permeability when compared with complement-intact animals (Table III , experiment A). These findings were extended by the use of another monoclonal IgA anti-DNP antibody (MOPC 315) in which lung permeability values reached a mean value of 0.61±0.03 in animals injected with antibody into the airways and with antigen into the vasculature, as contrasted with antigen deprived animals in which the same amount of antibody instilled into the airways produced a lung permeability value of 0.27±0.01 (Table III , experiments C and D). In a parallel series of animals that were complement depleted, a significant reduction in lung damage was noted in animals receiving both antigen and antibody, with a lung permeability value of 0.43±0.02 (Table III, experiment  C) . This represents a 53% reduction in the amount of lung damage produced by IgA immune complexes in animals that are complement depleted.
These studies were extended using airway instillation of IgG murine monoclonal anti-DNP isolated from XRPC myeloma. When antigen was injected intravenously, the mean lung permeability value in 10 animals was 0.62±0.03, as contrasted with 0.36±0.01 in animals deprived ofantigen (Table III, E and F). Not unexpectedly, in neutrophil-depleted animals, the ability of murine monoclonal IgG immune complexes to produce lung injury was markedly reduced, with a mean permeability value in four animals of 0.42±0.02, whereas in complement-depleted animals the lung permeability fell to a mean value of 0.35±0.04 (Table III , experiment E). These results should be compared with those from antigen-deprived animals, in which the lung permeability value was 0.32±0.01, whereas in antigen-deprived animals also depleted of neutrophils this value was 0.32±0.01 (Table III , experiment F). This indicates that neutrophil depletion leads to a 62% reduction in the intensity of lung injury when monoclonal IgG immune complexes were used, whereas in complement-depleted animals the same antibody produces a mean permeability value of 0.35±0.1, which indicates complete protection against lung injury. These data indicate that IgA immune complexes cause lung injury that is neutrophil independent but complement dependent, whereas lung injury produced by monoclonal IgG immune complexes is both neutrophil and complement dependent.
Comparative studies were carried out using rabbit polyclonal IgG antibody to BSA. The data are also shown in Table III (experiments G and H), where lung permeability values of 1.09±0.03 were found in neutrophil-intact animals. In contrast, in neutrophil-depleted animals, the mean lung permeability value fell to 0.27+0.01, whereas in complement-depleted animals the mean permeability value was 0.46±0.03, indicating 87 and 67% Morphometric studies oflung tissue. Morphometric analysis ofplastic-embedded (I ,um thick) sections oflung was undertaken to assess quantitative differences between animals developing acute lung injury induced by immune complexes containing IgA and IgG antibody. These data were then compared with those obtained from animals treated similarly but depleted of complement. We examined the lung interstitial capillary and the alveolar compartments; the data are summarized in Table   IV , where either linear distances (in micrometers) reflecting surface areas or particle (cell) counts are recorded.
As is evident from the data, the interstitial capillary vessels in rats receiving saline into the airways showed -., I
4.. V. show that complement depletion affords protection against IgA immune complex-induced lung injury. This confirms the data obtained by the lung permeability studies.
Discussion
The results presented in this paper reveal that acute lung injury in the rat can be induced by the deposition ofimmune complexes containing IgA. This would appear to be the first report complexes, leading to a glomerular proliferative response with the onset of hematuria (10) . Therefore, in the kidney as well as in blood vessels, there is good evidence that IgA immune complexes can cause tissue injury in humans and in animals. Our findings extend the spectrum of the pathogenic role for IgAcontaining immune complexes. The mechanism by which IgA immune complexes cause tissue injury appears clearly different than that for IgG-mediated tissue injury. IgG immune complexes, whether monoclonal or polyclonal, trigger tissue injury through the activation of the complement system with the subsequent attraction ofneutrophils into the site of immune complex deposits. Neutrophils are responsible for the subsequent tissue injury, apparently through the generation and release of toxic oxygen products (7) and perhaps also by a role played by released lysosomal proteases. There is evidence that neutrophils, monocytes, and alveolar macrophages contain receptors to IgA (24, 25) , which would be consistent with our data showing the ability ofIgA containing immune-complexes to activate neutrophils, resulting in production of oxygen-derived free radicals (Fig. 4) . Further, there is evidence that IgA in the polymeric form can react with human neutrophils in a manner that leads to the induction of chemotactic dysfunction (26) . IgA-mediated acute lung injury described in this report requires the participation of the complement system to initiate the injury, but the tissue injury does not require the participation of neutrophils. The reason for the apparent disparity for a neutrophil requirement in IgA-mediated acute lung injury is unknown. The fact that acute lung injury due to deposition of IgA immune complexes still occurs in the absence of neutrophils makes the cell type responsible for the injury unclear. One candidate for the purveyor of lung injury would be the alveolar macrophage. Alveolar macrophages can be activated to produce significant amounts of oxygen-free radicals when presented with stimuli such as immune complexes (27) . The hypothesis that alveolar macrophages may be involved in IgA-mediated acute lung injury could be related to the requirement for complement. IgA-containing immune complexes can activate complement, as shown in this study as well as another (28), although the complement activation activity is of a limited nature and may explain why other groups have had difficulty in detecting complement fixation (29) . The amount of complement activation products such as OSa or C3a may be insufficient to attract neutrophils but adequate to bring about activation ofalveolar and interstitial macrophages (30, 31) . This activation might then lead to the generation of oxygen-derived free radicals, which are highly toxic for the lung (reviewed, 32).
The data in this paper suggest that IgA-containing immune complexes have lung-damaging activity and that the nature of this effect is related to a requirement for complement but not for neutrophils. This is distinctly different from the manner in which IgG-containing immune complexes bring about tissue injury. The recognition that acute tissue injury can be provoked by a role for complement exclusive of the neutrophil represents a novel immunopathological mechanism that is as yet unexplained.
